Revofil Aquashine BTX is a cross-functional and multilevel anti-aging product. It is developed by Caregen Co. Ltd., a South Korea-based company that specializes in aesthetic products. Revofil Aquashine BTX is supplied as a transparent injectable gel in a 2ml prefilled syringe. A package of this product comes with a package insert and traceability labels. Infused with peptides, Revofil Aquashine BTX replenishes and regenerates the skin’s intercellular matrix to improve skin texture. At the same time, the filler tightens facial soft tissues and initiates skin renewal. This injectable filler is ideal for deep restructuring of the skin and correcting facial contours. Plus, Revofil Aquashine BTX is effective against vertical wrinkles above the upper lip, static and dynamic wrinkles on the forehead, and perioral wrinkles.
By replenishing the collagen levels of the skin, Revofil Aquashine BTX dramatically improves skin laxity. It effectively reduces the look of fine lines and wrinkles while restoring skin hydration and elasticity. Functioning as a form of mesotherapy, Revofil Aquashine BTX adds radiance to dull, tired skin to help bring about a rejuvenated look. At the same time, it boosts the levels of fibroblasts to deeply revitalize the skin. The cosmetic filler also helps restore healthy skin color and creates improved dermal radiance. In addition, Revofil Aquashine BTX can be used to remodel the face and its tissues to help restore the facial shape. It is also known to neutralize the actions of free radicals and strengthen blood vessel walls. Furthermore, Revofil Aquashine BTX is often used by doctors to improve microcirculation and normalize sebum production.
The active ingredients in Revofil Aquashine BTX work at a cellular level to enhance skin quality. Fortified with hyaluronic acid and bioactive peptides, the unique formulation offers a multi-tiered approach to restorative skin care. The non-cross-linked hyaluronic acid in the filer attracts water towards itself, thereby deeply hydrating the skin from within. As a result, the overall texture of the skin is improved, and the look of lines and wrinkles is significantly minimized. Thanks to its antioxidant effects, hyaluronic acid protects the skin from the damaging effects of free radicals. Compared to cross-linked hyaluronic acid, non-cross-linked hyaluronic acid is usually more susceptible to biodegradation. However, the peptides in Revofil Aquashine BTX have an inhibitory effect on hyaluronidase synthesis; this helps to increase the longevity of the hyaluronic acid.
Due to its unique pharmacodynamic properties, Revofil Aquashine BTX can be administered using a variety of injection techniques. This includes microinjections/micro bolus (at a needle depth of 3 to 4mm), linear retrograde injections (at a needle depth of 1.5 to 2mm), and epidermal injections (at a needle depth of 1mm). Furthermore, Revofil Aquashine BTX can be injected via dermaroller, microneedling via dermapen, or by using the cannula technique at the depth of subcutaneous tissues along arbitrary directions. Revofil Aquashine BTX is intended for professional use only. It should only be administered by a practitioner who has been suitably trained. Due to the risk of severe injection-related complications, patients are advised against injecting themselves. Keep in mind that the prefilled syringe is designed for single use only, so it should not be reused. Used needles and syringes should be safely disposed of in accordance with local regulations or FDA guidelines.
Revofil Aquashine BTX is designed to deliver long-lasting anti-aging results. In most cases, the aesthetic filler can last 10 to 12 months. Please note that the actual duration of effects may vary among individuals. Due to factors such as age, skin type, and atmospheric environment, the effects of Revofil Aquashine BTX may wear off sooner than expected. It is recommended to repeat treatment when signs of aging re-emerge.
Revofil Aquashine BTX is generally safe and well tolerated. It has a reasonably good safety profile and is not known to cause any allergenic properties. Revofil Aquashine BTX causes minimal downtime. In fact, most patients treated with Revofil Aquashine BTX can return to work immediately after the injection procedure. Please note Revofil Aquashine BTX is contraindicated in patients with a known allergy to hyaluronic acid and/or any other ingredients of the formulation.
Despite having a good safety profile, Revofil Aquashine BTX may occasionally cause adverse effects; however, most of these side effects are mostly mild and self-limiting in nature.
Common side effects of this filler include but are not limited to the following:
Less common side effects include the following:
Advise patients to seek medical help if any of their side effects worsen or persist. This section may not contain all the possible side effects associated with Revofil Aquashine BTX. The filler may cause unusual adverse reactions that are not described here. As a safety measure, patients should seek medical help if unusual symptoms occur after using Revofil Aquashine BTX. For a full list of side effects of Revofil Aquashine BTX, read the product’s package insert.
This filler contains a mixture of non-animal-sourced hyaluronic acid and revitalizing ingredients such as arginine and biomimetic peptides. These include oligopeptide-34, oligopeptide-62, decapeptide-29, oligopeptide-24, acetyl decapeptide-3, oligopeptide-51, and oligopeptide-72. They work in synergy to stimulate the production elastin and collagen; this results in the restoration of skin firmness, density, and elasticity. These biomimetic peptides essentially work by enhancing the body’s natural regenerative processes. They actively treat skin concerns rather than masking them.